Interleukin-6: biological features and clinical implications.
Tafuto
S
S
Immunohematology Service, National Cancer Institute, Napoli, Italy.
Silvestri
I
I
D'Andrea
P
P
Ronga
D
D
Abate
G
G
D000163:Acquired Immunodeficiency Syndrome / Q000503:physiopathology; D000818:Animals; D001172:Arthritis, Rheumatoid / Q000503:physiopathology; D016207:Cytokines / Q000502:physiology; D006412:Hematopoietic Stem Cells / Q000502:physiology; D006801:Humans; D007109:Immunity; D015850:Interleukin-6 / Q000502:physiology*; D008099:Liver / Q000502:physiology; D009369:Neoplasms / Q000503:physiopathology / Q000628:therapy; D009424:Nervous System Physiological Phenomena; D018123:Receptors, Interleukin / Q000502:physiology; D019947:Receptors, Interleukin-6; D015398:Signal Transduction; D013921:Thrombocytopenia / Q000628:therapy; D000093242:Interleukin-6 Inhibitors
D016207:Cytokines; D015850:Interleukin-6; D018123:Receptors, Interleukin; D019947:Receptors, Interleukin-6; D000093242:Interleukin-6 Inhibitors